APG Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $44.8M | Buy |
82,164
+18,728
| +30% | +$12.7M | 0.11% | 169 |
|
|
2026
Q1 | $42.5M | Sell |
63,436
-7,628
| -11% | -$5.84M | 0.13% | 136 |
|
|
2025
Q4 | $46.7M | Sell |
71,064
-6,387
| -8% | -$4.34M | 0.13% | 127 |
|
|
2025
Q3 | $37.1M | Sell |
77,451
-24
| -0% | -$13.6K | 0.1% | 158 |
|
|
2025
Q2 | $34.7M | Buy |
77,475
+68
| +0.1% | +$38K | 0.1% | 167 |
|
|
2025
Q1 | $45.4M | Sell |
77,407
-4,348
| -5% | -$2.99M | 0.14% | 126 |
|
|
2024
Q4 | $56.2M | Buy |
81,755
+59,984
| +276% | +$50.3M | 0.16% | 109 |
|
|
2024
Q3 | $20.5M | Sell |
21,771
-105,653
| -83% | -$118M | 0.14% | 114 |
|
|
2024
Q2 | $125M | Sell |
127,424
-16,343
| -11% | -$15.8M | 0.22% | 105 |
|
|
2024
Q1 | $128M | Sell |
143,767
-2,807
| -2% | -$2.67M | 0.22% | 107 |
|
|
2023
Q4 | $117M | Buy |
146,574
+3,077
| +2% | +$2.53M | 0.23% | 108 |
|
|
2023
Q3 | $118M | Sell |
143,497
-3,207
| -2% | -$2.52M | 0.24% | 95 |
|
|
2023
Q2 | $96.6M | Sell |
146,704
-6,205
| -4% | -$4.78M | 0.19% | 117 |
|
|
2023
Q1 | $116M | Sell |
152,909
-24,551
| -14% | -$18.5M | 0.25% | 99 |
|
|
2022
Q4 | $128M | Buy |
177,460
+18,869
| +12% | +$13.9M | 0.24% | 100 |
|
|
2022
Q3 | $112M | Sell |
158,591
-92,715
| -37% | -$58.4M | 0.29% | 90 |
|
|
2022
Q2 | $142M | Sell |
251,306
-123,289
| -33% | -$80.1M | 0.33% | 82 |
|
|
2022
Q1 | $235M | Sell |
374,595
-33,029
| -8% | -$20.9M | 0.44% | 59 |
|
|
2021
Q4 | $226M | Sell |
407,624
-8,200
| -2% | -$5.04M | 0.38% | 67 |
|
|
2021
Q3 | $217M | Sell |
415,824
-8,200
| -2% | -$5.09M | 0.39% | 65 |
|
|
2021
Q2 | $200M | Sell |
424,024
-877
| -0.2% | -$444K | 0.34% | 76 |
|
|
2021
Q1 | $171M | Sell |
424,901
-31,568
| -7% | -$15.4M | 0.29% | 84 |
|
|
2020
Q4 | $180M | Buy |
456,469
+115,711
| +34% | +$62.5M | 0.29% | 78 |
|
|
2020
Q3 | $163M | Buy |
340,758
+24,500
| +8% | +$14.9M | 0.28% | 87 |
|
|
2020
Q2 | $176M | Buy |
316,258
+264,471
| +511% | +$150M | 0.32% | 75 |
|
|
2020
Q1 | $25.3M | Buy |
51,787
+21,377
| +70% | +$8.82M | 0.05% | 354 |
|
|
2019
Q4 | $10.2M | Buy |
30,410
+5,950
| +24% | +$2M | 0.02% | 564 |
|
|
2019
Q3 | $6.22M | Sell |
24,460
-124,922
| -84% | -$37M | 0.01% | 654 |
|
|
2019
Q2 | $41.1M | Buy |
149,382
+100
| +0.1% | +$33.3K | 0.07% | 286 |
|
|
2019
Q1 | $54.6M | Buy |
149,282
+130,900
| +712% | +$53.9M | 0.1% | 243 |
|
|
2018
Q4 | $6.01M | Sell |
18,382
-200
| -1% | -$73.2K | 0.01% | 534 |
|
|
2018
Q3 | $6.46M | Hold |
18,582
| – | – | 0.01% | 570 |
|
|
2018
Q2 | $5.49M | Hold |
18,582
| – | – | 0.01% | 582 |
|
|
2018
Q1 | $5.2M | Hold |
18,582
| – | – | 0.01% | 573 |
|
|
2017
Q4 | $5.82M | Sell |
18,582
-2,375
| -11% | -$962K | 0.01% | 592 |
|
|
2017
Q3 | $9.37M | Buy |
20,957
+2,100
| +11% | +$999K | 0.02% | 531 |
|
|
2017
Q2 | $9.26M | Sell |
18,857
-31,690
| -63% | -$13.9M | 0.02% | 511 |
|
|
2017
Q1 | $19.6M | Sell |
50,547
-32,212
| -39% | -$11.9M | 0.04% | 419 |
|
|
2016
Q4 | $28.8M | Sell |
82,759
-13,600
| -14% | -$5.17M | 0.05% | 363 |
|
|
2016
Q3 | $38.7M | Sell |
96,359
-300
| -0.3% | -$120K | 0.07% | 328 |
|
|
2016
Q2 | $33.8M | Buy |
96,659
+10,600
| +12% | +$4.08M | 0.06% | 326 |
|
|
2016
Q1 | $31M | Buy |
86,059
+11,467
| +15% | +$4.73M | 0.06% | 325 |
|
|
2015
Q4 | $40.5M | Sell |
74,592
-12,493
| -14% | -$6.77M | 0.09% | 260 |
|
|
2015
Q3 | $40.5M | Sell |
87,085
-6,406
| -7% | -$3.44M | 0.09% | 258 |
|
|
2015
Q2 | $47.7M | Buy |
93,491
+1,347
| +1% | +$657K | 0.1% | 258 |
|
|
2015
Q1 | $41.6M | Sell |
92,144
-5,908
| -6% | -$2.5M | 0.09% | 275 |
|
|
2014
Q4 | $40.2M | Buy |
98,052
+4,913
| +5% | +$1.93M | 0.08% | 284 |
|
|
2014
Q3 | $33.6M | Sell |
93,139
-711
| -0.8% | -$238K | 0.07% | 300 |
|
|
2014
Q2 | $26.5M | Buy |
93,850
+7,358
| +9% | +$2.18M | 0.06% | 333 |
|
|
2014
Q1 | $26M | Buy |
86,492
+12,116
| +16% | +$3.73M | 0.07% | 290 |
|
|
2013
Q4 | $20.5M | Sell |
74,376
-3,684
| -5% | -$1.06M | 0.06% | 321 |
|
|
2013
Q3 | $24.4M | Sell |
78,060
-14,078
| -15% | -$3.7M | 0.08% | 291 |
|
|
2013
Q2 | $20.7M | Buy |
+92,138
| New | +$21.5M | 0.06% | 326 |
|
Other funds holding REGN
VCM
VPM
N
APG Asset Management's REGN Position: Q2 2026 in Review
APG Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 30% in Q2 2026, buying an estimated $12.7M and bringing the position to 82,164 shares worth $44.8M. The position accounts for 0.11% of the portfolio, ranked #169.
APG Asset Management first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $235M in Q1 2022. 1,073 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- APG Asset Management held 82,164 shares of Regeneron Pharmaceuticals worth $44.8M as of Q2 2026.
- APG Asset Management bought 18,728 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $12.7M.
- Regeneron Pharmaceuticals made up 0.11% of APG Asset Management's portfolio in Q2 2026, its #169 holding.
- APG Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- APG Asset Management's Regeneron Pharmaceuticals position peaked at $235M in Q1 2022.
- 1,073 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on APG Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.